[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"young-adult-cancer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:young-adult-cancer":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,45,78,104,142],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100608029","comprehensive-care-for-aya-needs-assessment-survey-100608029",false,"NCT07196241","Comprehensive Care for AYA: Needs Assessment Survey","Inclusion Criteria:\n\n* Individuals diagnosed with cancer between the ages of 15-39 per self-report. Participants may be enrolled at any age provided diagnosis was between ages 15-39.\n* Individuals who have received or are receiving cancer-directed treatment (chemotherapy, immunotherapy, surgery and\u002For radiation) at one of the participating centers per self-report.\n\nExclusion Criteria:\n\n* Severe emotional distress or anxiety that would limit compliance with study requirements per self-report.","ALL","15 Years",{"count":18,"type":19},300,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to assess gaps in education about exercise, sexual health, fertility, survivorship, financial issues, interpersonal relationships, and clinical trial participation among adolescents and young adults with cancer.\n\nParticipants will be asked to complete a series of questionnaires.",[23,24,25],"Cancer","Young Adult Cancer","Adolescent Cancer",[27,28,23,29,30,31],"Adolescent","Young Adult","AYA","Questionnaire","Needs assessment","RECRUITING","2026-05-21",{"date":35,"type":36},"2026-05-26","ACTUAL",{"date":38,"type":19},"2026-06",{"date":40,"type":19},"2026-10",{"name":42,"class":43},"Wake Forest University Health Sciences","OTHER",2,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":15,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":77},"100572369","pilot-study-of-mindset-moments-among-adolescent-and-young-adult-cancer-survivors-100572369","NCT06732375","Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors","Inclusion Criteria:\n\n* 19-25 years of age\n* Prior AYA cancer diagnosis\n* Completed primary treatment for their cancer\n* Score of 3 or above on the Distress Thermometer at the time of recruitment\n\nExclusion Criteria:\n\n* Individuals without legal capacity to give consent\n* Individuals who are not fluent in reading, writing, and speaking English",true,"19 Years","25 Years",{"count":55,"type":19},40,"INTERVENTIONAL",[58],"NA","The purpose of this study is to evaluate the feasibility and acceptability of the Mindset Moments™ (MM™) program in managing psychological distress and resiliency in adolescent and young adult cancer survivors.\n\nStudy participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities such as guided imageries and CBT check in within the app. Participants will also be asked to complete an online survey at the time of enrollment and at 4 and 8 weeks.",[23,61,24,62],"Youth Cancer","Distress, Psychological",[64,65,66,67],"young adult cancer survivor","distress","youth cancer survivor","resilience","2026-05-05",{"date":70,"type":36},"2026-05-06",{"date":72,"type":36},"2025-06-13",{"date":74,"type":19},"2027-03",{"name":76,"class":43},"Duke University",1,{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":15,"minAge":85,"maxAge":86,"enrollmentInfo":87,"targetDuration":4,"studyType":56,"phases":89,"briefSummary":90,"conditions":91,"keywords":92,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":77},"100610178","life-at-1004-an-immersive-social-virtual-reality-vr-education-tool-for-adolescent-and-young-adult-cancer-patients-and-caregivers-100610178","NCT07224204","Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers","Life at 100.4: An Immersive Social Virtual Reality Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers","Inclusion Criteria:\n\n* Newly diagnosed with a malignancy or bone marrow failure condition\n* Planned to receive chemotherapy and receive a central line\n\nExclusion Criteria:\n\n* Medical contraindication to virtual reality including head wounds and history of seizure with flashing lights\n* No plan to receive chemotherapy","13 Years","39 Years",{"count":88,"type":19},45,[58],"The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.",[23,25,24],[93,94],"Adolescent Cancer Patients and Caregivers","Young Adult Cancer Patients and Caregivers","2026-02-24",{"date":97,"type":36},"2026-02-25",{"date":99,"type":36},"2026-02-11",{"date":101,"type":19},"2027-04",{"name":103,"class":43},"Yale University",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":15,"minAge":111,"maxAge":112,"enrollmentInfo":113,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":115,"conditions":116,"keywords":122,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":5},"100611871","caya-cancer-retrospective-cohort-study-100611871","NCT07246213","CAYA Cancer Retrospective Cohort Study","Improving Cancer Outcomes for Children, Adolescents, and Young Adults: A Multicenter Retrospective Cohort Study on Treatment Failure and Toxicity in Low- and Middle-Income Countries","Inclusion Criteria:\n\nSubjects must meet all the following criteria to be included in this registry:\n\n1. Participants must be willing and able to provide informed consent prior to enrollment in the registry.\n\n   1. For minors or individuals unable to provide informed consent, assent must be obtained along with consent from a legal guardian.\n   2. Note: Exemption applies to this criterion when waiver of informed consent\u002Fassent is granted by Institutional Review Board(IRB)\u002FIndependent Ethics Committee(IEC)\u002FCompetent Authorities(CAs).\n2. A confirmed diagnosis of any type of cancer within the 15 years prior to the site's activation date.\n3. Age 0 to 21 years at the time of diagnosis.\n4. Received substantial anti-cancer treatment at the participating center, including but not limited to:\n\n   1. Chemotherapy\n   2. Surgery\n   3. Radiation therapy\n   4. Immunotherapy\n5. Medical records are available and accessible for review\n\nExclusion Criteria:\n\n* Subjects meeting any of the following criteria will be excluded from this registry:\n\n  1. Patients who only visited the participating center for:\n\n     1. Consultation without subsequent primary anti-cancer treatment at the participating center\n     2. Pathology, radiology, or other diagnostic evaluations without treatment","0 Years","21 Years",{"count":114,"type":19},18000,"Despite advances in cancer treatment, significant disparities in outcomes persist between high-income countries (HICs) and low-and middle-income countries (LMICs). Around 80% of children with cancer live in LMICs, where they face challenges such as delayed diagnosis, misdiagnosis, comorbidities, distance to treatment, financial barriers, and limited access to risk-adapted therapies.\n\nAcute lymphoblastic leukemia(ALL)\u002Flymphoblastic lymphoma(LBL), for example, is one of the greatest success stories in pediatric oncology, however, such improvements are not evenly distributed worldwide, and the outcomes for leukemia patients are poorer in LMICs compared to HICs, primarily due to reduced access to quality healthcare.\n\nThis study aims to assess cancer treatment outcomes in LMICs, focusing on acute lymphoblastic leukemia\u002Flymphoblastic lymphoma. The findings will inform future studies to implement evidence-based interventions that improve care quality and reduce treatment failures through targeted strategies.",[117,118,24,25,119,120,121],"Acute Lymphoblastic Leukemia","Lymphoblastic Lymphoma","Childhood Cancers","Acute Lymphoblastic Leukemia (ALL)","Lymphoblastic Lymphoma (LBL)",[123,124,125,126,127,128,129,130,131,132],"Cancer outcomes","Low- and Middle-Income Countries (LMICs)","Childhood cancer","Adolescent and young adult cancer (CAYA)","Treatment failure","Therapy-related toxicities","Retrospective cohort","Leukemia outcomes","Oncology disparities","High-Income Countries (HICs)","2025-12-12",{"date":135,"type":36},"2025-12-19",{"date":137,"type":36},"2025-06-04",{"date":139,"type":19},"2028-12-04",{"name":141,"class":43},"Resonance, Inc.",{"id":143,"slug":144,"hasResults":11,"nctId":145,"briefTitle":146,"officialTitle":147,"acronym":4,"eligibilityCriteria":148,"healthyVolunteers":11,"sex":15,"minAge":149,"maxAge":4,"enrollmentInfo":150,"targetDuration":4,"studyType":56,"phases":152,"briefSummary":153,"conditions":154,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":156,"lastUpdatePostDateStruct":157,"startDateStruct":159,"completionDateStruct":161,"leadSponsor":163,"locationsCount":77},"100463446","yoga-for-young-adults-affected-by-cancer-100463446","NCT05314803","Yoga for Young Adults Affected by Cancer","Yoga for Young Adults Affected by Cancer: Exploring Implementation and Effectiveness of an Online Program","Inclusion Criteria:\n\n1. Adult aged 18 years or older;\n2. Diagnosed with cancer between the ages of 18-39 years;\n3. At any stage of their cancer experience (i.e., on- or off-treatment);\n4. Able to safely engage in yoga, as assessed by completing the Get Active Questionnaire and obtaining medical clearance (if indicated).\n5. Willing and able to complete informed consent, questionnaires, physical assessments, and an interview in English.\n\nExclusion Criteria:\n\n1\\. Previous enrolment in the study, to avoid contamination and\u002For ceiling effects.","18 Years",{"count":151,"type":19},500,[58],"Yoga may enhance physical and psychological outcomes among young adults affected by cancer. Yet, yoga has rarely been studied in this population. We developed and piloted a yoga program, which is now ready for implementation and evaluation. This single-group, mixed-methods project will explore effectiveness and implementation of the yoga program.",[24,155],"Young Adult Oncology","2022-03-29",{"date":158,"type":36},"2022-04-06",{"date":160,"type":36},"2021-09-01",{"date":162,"type":19},"2028-12-01",{"name":164,"class":43},"University of Calgary"]